Home » Topics » Regulatory

Regulatory
RSS

European Commission approves trastuzumab biosimilar Ontruzant

Nov. 20, 2017

FDA first to approve Hemlibra for hemophilia A

Nov. 17, 2017

FDA approves Mepsevii for mucopolysaccharidosis type VII

Nov. 16, 2017

FDA approves Heplisav-B for prevention of hepatitis B in adults

Nov. 10, 2017

FDA approves Adcetris in new indication

Nov. 10, 2017

FDA approves Prevymis for CMV prevention in adult HSCT recipients

Nov. 9, 2017

FDA approves Keryx's Auryxia in new indication

Nov. 8, 2017

Nicox announces FDA approval of Vyzulta, recaps pipeline progress

Nov. 3, 2017

Calquence approved and available to order in U.S. for mantle cell lymphoma

Nov. 2, 2017

Ebola vaccine approved in China

Oct. 26, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 22, 2025.
In 2025, science’s biggest story was political
BioWorld
In 2025, science saw its breakthroughs, which BioWorld will be covering as part of our end-of-the-year wrap-up. But the biggest science story of 2025 is not about...
FDA says yes to Cytokinetics’ aficamten, now Myqorzo, in oHCM
BioWorld
Cytokinetics Inc. scored U.S. FDA marketing clearance Dec. 19 for Myqorzo (aficamten) 5-mg, 10-mg, 15-mg, and 20-mg tablets to improve functional capacity and...
Conjugating ferrocene to GPX4 inhibitors to promote ferroptosis
BioWorld Science
Small molecules that induce iron-dependent oxidative cell death known as ferroptosis can be effective against tumors that are resistant to other therapies....